Health
FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014 | FDA – FDA.gov
FDA approves Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition.

For Immediate Release:
June 04, 2021
Today, the U.S. Food and Drug Administration approved Wegovy (semaglutide) injection (2.4 mg once weekly) for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), for use in addition to a reduced calorie diet and increased physical activity. This under-the-skin injection is the first approved drug for chronic weight management in adults with…
-
Noosa News24 hours ago
Woman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News22 hours ago
Working for someone else made it hard to care for my daughter. So I quit
-
Business9 hours ago
Ford CEO makes stunning prediction about artificial intelligence
-
General18 hours ago
‘Potential’ hacker contacts Qantas over data breach